Several cancer types, including TNBC, have been shown to depend heavily on NADPH derived from H6PD, an enzyme in the PPP, to provide the reducing equivalents required for DHFR activity, with loss of H6PD resulting in folate deficiency [62]. The gene discussed is H6PD; the disease is cancer.